Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Biltricide 600mg tablets
0505050P0BBAAAA
|
Biltricide | Praziquantel | Infections | No data available |
|
Blemix 100mg tablets
0501030P0BCABAB
|
Blemix | Minocycline hydrochloride | Infections | No data available |
|
Blemix 50mg tablets
0501030P0BCAAAA
|
Blemix | Minocycline hydrochloride | Infections | No data available |
|
Boceprevir 200mg capsules
0503032A0AAAAAA
|
Boceprevir | Boceprevir | Infections | No data available |
|
Boots Threadworm Treatment 100mg chewable tablets
0505010D0BEAAAD
|
Boots Threadworm Treatment | Mebendazole | Infections | No data available |
|
Britacef 1.5g powder for solution for injection vials
0501021J0BCACAC
|
Britacef | Cefuroxime sodium | Infections | No data available |
|
Britacef 250mg powder for solution for injection vials
0501021J0BCAAAA
|
Britacef | Cefuroxime sodium | Infections | No data available |
|
Britacef 750mg powder for solution for injection vials
0501021J0BCABAB
|
Britacef | Cefuroxime sodium | Infections | No data available |
|
Cabotegravir 30mg tablets
0503010AWAAAAAA
|
Cabotegravir | Cabotegravir | Infections | No data available |
|
Cabotegravir 600mg/3ml prolonged-release inj vials
0503010AWAAABAB
|
Cabotegravir | Cabotegravir | Infections | No data available |
|
Cancidas 50mg pdr for concentrate for inf vials
0502040C0BBAAAA
|
Cancidas | Caspofungin | Infections | No data available |
|
Cancidas 70mg powder for solution for infusion vials
0502040C0BBABAB
|
Cancidas | Caspofungin | Infections | No data available |
|
Capastat 1g powder for solution for injection vials
0501090C0BBAAAA
|
Capastat | Capreomycin | Infections | No data available |
|
Capreomycin 1g powder for solution for injection vials
0501090C0AAAAAA
|
Capreomycin | Capreomycin | Infections | No data available |
|
Caspofungin 70mg powder for solution for infusion vials
0502040C0AAABAB
|
Caspofungin | Caspofungin | Infections | No data available |
|
Cayston 75mg neb soln vials with Altera Nebuliser Handset
0501023A0BCAAAF
|
Cayston | Aztreonam | Infections | No data available |
|
Cefaclor 250mg/5ml oral suspension sugar free
0501021A0AAAKAK
|
Cefaclor | Cefaclor | Infections | No data available |
|
Cefadroxil 125mg/5ml oral suspension
0501021B0AAABAB
|
Cefadroxil | Cefadroxil | Infections | No data available |
|
Cefadroxil 250mg/5ml oral suspension
0501021B0AAACAC
|
Cefadroxil | Cefadroxil | Infections | No data available |
|
Cefadroxil 500mg/5ml oral suspension
0501021B0AAADAD
|
Cefadroxil | Cefadroxil | Infections | No data available |
|
Cefalexin 500mg/5ml oral suspension
0501021L0AAAEAE
|
Cefalexin | Cefalexin | Infections | No data available |
|
Cefamandole 1g powder for solution for injection vials
0501020T0AAABAB
|
Cefamandole | Cefamandole | Infections | No data available |
|
Cefazolin 1g powder for solution for injection vials
0501020V0AAABAB
|
Cefazolin sodium (Parenteral) | Cefazolin sodium | Infections | No data available |
|
Cefazolin 2g powder for solution for injection vials
0501020V0AAADAD
|
Cefazolin sodium (Parenteral) | Cefazolin sodium | Infections | No data available |
|
Cefazolin 500mg powder for solution for injection vials
0501020V0AAAAAA
|
Cefazolin sodium (Parenteral) | Cefazolin sodium | Infections | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.